Statistical modeling for selecting housekeeper genes
暂无分享,去创建一个
Charles M Perou | Aniko Szabo | C. Perou | J. Quackenbush | P. Bernard | M. Karaca | A. Szabo | Mehmet Karaca | Laurent Perreard | John F Quackenbush | Philip S Bernard | Laurent Perreard | Aniko Szabo
[1] Carl T. Wittwer,et al. Rapid Cycle Real-Time PCR — Methods and Applications , 2002, Springer Berlin Heidelberg.
[2] W. Taylor,et al. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential. , 1994, Analytical biochemistry.
[3] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[4] E. Spanakis,et al. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. , 1993, Nucleic acids research.
[5] P. J. Higgins,et al. Control selection for RNA quantitation. , 2000, BioTechniques.
[6] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[7] Charles M. Perou,et al. Tumor classification using gene expression patterns from DNA microarrays , 2000 .
[8] V. Carey,et al. Mixed-Effects Models in S and S-Plus , 2001 .
[9] R. Rasmussen. Quantification on the LightCycler , 2001 .
[10] A. Eggert,et al. Relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control. , 2000, BioTechniques.
[11] S. Akilesh,et al. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.
[12] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] Paul S Mischel,et al. Molecular Analysis of Glioblastoma: Pathway Profiling and Its Implications for Patient Therapy , 2003, Cancer biology & therapy.
[14] F. Pichaud,et al. Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors. , 1997, Endocrinology.
[15] L J Kricka,et al. Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer. , 2000, Clinical chemistry.
[16] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[17] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[18] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[19] P. Bernard,et al. Profiling Breast Cancer Using Real-Time Quantitative PCR , 2004 .
[20] J. SantaLucia,et al. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Yolken,et al. Methods to optimize the generation of cDNA from postmortem human brain tissue. , 2003, Brain research. Brain research protocols.
[22] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[23] T. Grogan,et al. Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.